{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:56:32Z","timestamp":1777589792090,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":5143,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1194\/jlr.m600239-jlr200","type":"journal-article","created":{"date-parts":[[2006,7,22]],"date-time":"2006-07-22T00:54:25Z","timestamp":1153529665000},"page":"2161-2170","source":"Crossref","is-referenced-by-count":11,"title":["Conditional expression of human acid \u03b2-glucosidase improves the visceral phenotype in a Gaucher disease mouse model"],"prefix":"10.1016","volume":"47","author":[{"given":"Ying","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Hai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana","family":"Leonova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M600239-JLR200_bib1","series-title":"Gaucher disease. In The Metabolic and Molecular Basis of Inherited Disease","first-page":"3635","author":"Beutler","year":"2001"},{"key":"10.1194\/jlr.M600239-JLR200_bib2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00018-002-8458-y","article-title":"Gaucher disease: perspectives on a prototype lysosomal disease.","volume":"59","author":"Zhao","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1194\/jlr.M600239-JLR200_bib3","first-page":"212","article-title":"Gaucher disease: molecular heterogeneity and phenotype-genotype correlations.","volume":"45","author":"Theophilus","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"10.1194\/jlr.M600239-JLR200_bib4","first-page":"176","article-title":"Infantile Gaucher's disease: electron microscopic and histochemical studies of a cerebral biopsy.","volume":"26","author":"Volk","year":"1967","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1194\/jlr.M600239-JLR200_bib5","first-page":"33","article-title":"Phenotypic manifestations of Gaucherdisease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients.","volume":"95","author":"Kolodny","year":"1982","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1194\/jlr.M600239-JLR200_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.genom.4.070802.110415","article-title":"Enzyme therapy for lysosomal storage disease: principles, practice, and prospects.","volume":"4","author":"Grabowski","year":"2003","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1194\/jlr.M600239-JLR200_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.med.57.110104.115650","article-title":"Enzyme replacement for lysosomal diseases.","volume":"57","author":"Brady","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1194\/jlr.M600239-JLR200_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/B:BOLI.0000031101.12838.c6","article-title":"Enzyme replacement and enhancement therapies for lysosomal diseases.","volume":"27","author":"Desnick","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1194\/jlr.M600239-JLR200_bib9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0888-7543(92)90247-P","article-title":"Structure and evolution of the human prosaposin chromosomal gene.","volume":"13","author":"Rorman","year":"1992","journal-title":"Genomics."},{"key":"10.1194\/jlr.M600239-JLR200_bib10","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.2842863","article-title":"Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus.","volume":"241","author":"O'Brien","year":"1988","journal-title":"Science."},{"key":"10.1194\/jlr.M600239-JLR200_bib11","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1021\/bi00412a050","article-title":"Biosynthesis and molecular cloning of sulfated glycoprotein 1 secreted by rat Sertoli cells: sequence similarity with the 70-kilodalton precursor to sulfatide\/GM1 activator.","volume":"27","author":"Collard","year":"1988","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.M600239-JLR200_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0079-6603(00)66030-0","article-title":"Molecular and cell biology of acid \u03b2-glucosidase and prosaposin.","volume":"66","author":"Qi","year":"2001","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1194\/jlr.M600239-JLR200_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2760(92)90210-M","article-title":"Activator proteins and topology of lysosomal sphingolipid catabolism.","volume":"1126","author":"Furst","year":"1992","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M600239-JLR200_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0014-5793(97)01302-1","article-title":"Saposins (sap) A and C activate the degradation of galactosylceramide in living cells.","volume":"417","author":"Harzer","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1194\/jlr.M600239-JLR200_bib15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/hmg\/5.6.711","article-title":"Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids.","volume":"5","author":"Fujita","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1194\/jlr.M600239-JLR200_bib16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/hmg\/10.9.927","article-title":"A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation.","volume":"10","author":"Hulkova","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1194\/jlr.M600239-JLR200_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/bj2850481","article-title":"Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.","volume":"285","author":"Paton","year":"1992","journal-title":"Biochem. J."},{"key":"10.1194\/jlr.M600239-JLR200_bib18","doi-asserted-by":"crossref","first-page":"31918","DOI":"10.1074\/jbc.M302752200","article-title":"Saposin C is required for normal resistance of acid \u03b2-glucosidase to proteolytic degradation.","volume":"278","author":"Sun","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M600239-JLR200_bib19","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1194\/jlr.M500202-JLR200","article-title":"Gaucher disease mouse models: point mutations at the acid \u03b2-glucosidase locus combined with low-level prosaposin expression lead to disease variants.","volume":"46","author":"Sun","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M600239-JLR200_bib20","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid \u03b2-glucosidase deficiency: the defect in Gaucher disease.","volume":"163","author":"Xu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1194\/jlr.M600239-JLR200_bib21","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1073\/pnas.89.12.5547","article-title":"Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.","volume":"89","author":"Gossen","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M600239-JLR200_bib22","doi-asserted-by":"crossref","first-page":"10933","DOI":"10.1073\/pnas.93.20.10933","article-title":"Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.","volume":"93","author":"Kistner","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M600239-JLR200_bib23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0959-4388(00)00127-6","article-title":"Tetracycline-regulated gene expression in the brain.","volume":"10","author":"Mansuy","year":"2000","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1194\/jlr.M600239-JLR200_bib24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1053\/jhep.2003.50196","article-title":"Conditional tetracycline-regulated expression of TGF-\u03b21 in liver of transgenic mice leads to reversible intermediary fibrosis.","volume":"37","author":"Ueberham","year":"2003","journal-title":"Hepatology."},{"key":"10.1194\/jlr.M600239-JLR200_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1096-7192(02)00114-2","article-title":"Prosaposin: threshold rescue and analysis of the \u201cneuritogenic\u201d region in transgenic mice.","volume":"76","author":"Sun","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1194\/jlr.M600239-JLR200_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1203\/00006450-199602000-00021","article-title":"Turnover and distribution of intravenously administered mannose-terminated human acid \u03b2-glucosidase in murine and human tissues.","volume":"39","author":"Xu","year":"1996","journal-title":"Pediatr. Res."},{"key":"10.1194\/jlr.M600239-JLR200_bib27","first-page":"1","article-title":"Antigen markers of macrophage differentiation in murine tissues.","volume":"181","author":"Gordon","year":"1992","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1194\/jlr.M600239-JLR200_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/mgme.2000.3035","article-title":"Fate and sorting of acid \u03b2-glucosidase in transgenic mammalian cells.","volume":"70","author":"Leonova","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"10.1194\/jlr.M600239-JLR200_bib29","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s001090050279","article-title":"Long-term expression and secretion of human glucocerebrosidase by primary murine and human myoblasts and differentiated myotubes.","volume":"76","author":"Liu","year":"1998","journal-title":"J. Mol. Med."},{"key":"10.1194\/jlr.M600239-JLR200_bib30","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1086\/498652","article-title":"The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy.","volume":"77","author":"Du","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1194\/jlr.M600239-JLR200_bib31","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jgm.901","article-title":"AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease.","volume":"8","author":"McEachern","year":"2006","journal-title":"J. Gene Med."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520434030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520434030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M600239-JLR200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T23:50:44Z","timestamp":1637452244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520434030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0022227520434030"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m600239-jlr200","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}